iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -2.25%73.301.0%$1706.95m
AMGNAmgen, Inc. -0.64%217.791.3%$925.22m
REGNRegeneron Pharmaceuticals, Inc. -0.62%509.182.6%$841.05m
BIIBBiogen, Inc. 0.54%318.671.5%$810.06m
VRTXVertex Pharmaceuticals, Inc. -1.61%245.651.9%$646.92m
ILMNIllumina, Inc. 0.90%283.523.5%$496.24m
MRNAModerna, Inc. -3.12%31.410.0%$494.74m
ALXNAlexion Pharmaceuticals, Inc. -3.40%95.212.0%$298.62m
AAgilent Technologies, Inc. 1.70%77.991.6%$232.30m
INCYIncyte Corp. -1.55%86.392.5%$217.62m
EXASEXACT Sciences Corp. 1.33%67.2521.0%$184.55m
SGENSeattle Genetics, Inc. 0.51%120.296.1%$162.12m
BMRNBioMarin Pharmaceutical, Inc. -0.57%79.154.3%$149.71m
NVAXNovavax, Inc. -1.63%16.90114.7%$133.44m
IMMUImmunomedics, Inc. 4.72%19.3011.9%$126.85m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.